Posiformin® (Ointment) Instructions for Use
Marketing Authorization Holder
Ursapharm Arzneimittel, GmbH (Germany)
ATC Code
S01AX05 (Bibrocathol)
Active Substance
Bibrocathol (Rec.INN registered by WHO)
Dosage Form
| Posiformin® | Eye ointment 2%: tube 5 g |
Dosage Form, Packaging, and Composition
Eye ointment homogeneous, suspension, from yellow to grey-yellow in color.
| 1 g | |
| Bibrocathol | 20 mg |
Excipients: white soft paraffin – 666.4 mg, liquid paraffin – 245 mg, anhydrous lanolin – 68.6 mg.
5 g – aluminum tubes (1) – cardboard packs.
Clinical-Pharmacological Group
Drug with antimicrobial action for topical use in ophthalmology
Pharmacotherapeutic Group
Drugs for the treatment of eye diseases – other antimicrobial drugs
Pharmacological Action
Bibrocathol is a phenolic derivative of tetrabromopyrocatechol and bismuth hydroxide, possessing antiseptic and astringent properties, as well as the ability to inhibit the secretion of mucous membranes and wounds.
On the mucous membrane and wound surface, Bibrocathol causes protein precipitation and tightening of the superficial tissue layers. This leads to the formation of a protective layer that prevents the penetration of pathogenic microorganisms. Such an astringent effect causes non-specific inhibition of inflammation and secretion.
Pharmacokinetics
Bibrocathol is almost insoluble in water and therefore practically does not penetrate into the eye tissues and intraocular fluid.
The use of bibrocathol in ophthalmology is limited to the local treatment of non-specific irritations and inflammations, as well as the treatment of wounds of the external eye membranes. After topical ophthalmic application, significant systemic absorption of bibrocathol does not occur.
Indications
Non-specific irritations of the external coverings of the eye of non-infectious origin; chronic inflammation of the eyelid margin (chronic blepharitis); fresh non-infected corneal wounds.
ICD codes
| ICD-10 code | Indication |
| H01.0 | Blepharitis |
| H01.1 | Noninfectious dermatoses of eyelid |
| H16.0 | Corneal ulcer |
| H16.1 | Other superficial keratitis without conjunctivitis |
| ICD-11 code | Indication |
| 9A01.3 | Infectious blepharitis |
| 9A02.Z | Inflammatory disorders of eyelid, unspecified |
| 9A06 | Certain specified disorders of the eyelids |
| 9A72 | Traumatic keratitis |
| 9A76 | Corneal ulcer |
| 9A78.Z | Other diseases of cornea, unspecified |
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
Apply a small amount of ointment, approximately a 1 cm strip, into the conjunctival sac of the affected eye(s) or directly onto the affected eyelid margin.
Use the preparation three to five times daily at regular intervals.
Continue application until symptoms resolve completely.
Do not use for more than 14 consecutive days without re-evaluation by a physician.
No dose adjustment is required for elderly patients or for patients with renal or hepatic impairment.
Administer the ointment last if using multiple topical ophthalmic products; maintain a 5-minute interval between applications.
Wash hands thoroughly before and after application.
Avoid contact between the tube tip and the eye, eyelids, or any other surface to prevent contamination.
Adverse Reactions
Immune system disorders rarely – hypersensitivity reactions; eye irritation (itching, hyperemia or swelling of the eyes, eye pain, facial swelling, facial flushing).
Contraindications
Hypersensitivity to the active substance.
Use in Pregnancy and Lactation
Clinical data on the use of bibrocathol during pregnancy or breastfeeding are not available.
Use is only possible if the expected benefit to the mother outweighs the potential risk of side effects to the fetus and child.
Special Precautions
Contact lenses should not be worn during the course of treatment.
Effect on ability to drive vehicles and operate machinery
Immediately after application, due to the oily consistency, a short-term decrease in visual acuity is possible, which may affect the speed of reaction when driving vehicles or operating machinery.
Storage Conditions
Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.
Dispensing Status
Rx Only
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical Disclaimer